Tag: glioblastoma
-
Yale Highlights AI's Mental Health Impact, Cancer Breakthroughs, and Arts Recognition
Yale University addresses AI-induced psychosis, unveils promising T-cell therapy for aggressive brain cancer, and prepares to honor conductor Gustavo Dudamel. The institution also welcomed its new class of 2030 students.
Science & TechnologyHealthEntertainmentWorldArtificial IntelligenceMedical ScienceEnvironmentEducationMusicMiddle East PsychosisGlioblastomaT-cell therapyGustavo DudamelYale UniversityHigher EducationUniversity
-
Yale University Highlights Breakthroughs in Cancer Treatment, Education, and Cultural Preservation
Yale University showcases advancements in T-cell therapy for aggressive brain cancer, continued support for public school teachers, and significant cultural preservation efforts, including ancient Egyptian language research and a 17th-century song's revival.
EducationScience & TechnologyHealthWorldMedical ScienceAstronomy and SpaceEnvironmentSocial Issues Yale UniversityT-cell therapyglioblastomaAncient EgyptCultural PreservationMedical ResearchUniversity
-
Immune Activation Key to CAR T Therapy Success in Glioblastoma, Penn Medicine Finds
Penn Medicine research reveals glioblastoma patients on dual-target CAR T cell therapy live longer with activated natural killer cells, while non-responders show more immunosuppressive cells, paving the way for therapy improvements.
HealthBusinessPolitics and GovernmentLaw EnforcementMedical ScienceReal EstateGeneral PoliticsEnvironmentSocial Issues GlioblastomaCAR T cell therapyPenn MedicineNatural Killer CellsImmunosuppressionCancer ResearchImmunotherapy
-
Media Monitor: Jason Collins, first openly gay NBA player, dies at 47
USA Today is reporting that Jason Collins, the first openly gay player in NBA history, has died at 47 after a battle with glioblastoma.
SportHealthMedical ScienceSocial Issues Jason CollinsNBAGlioblastomaDeathBasketballLGBTQ+SportsUSA TODAY
-
NIH-Funded Study Reveals Testosterone May Suppress Brain Tumor Growth in Men
Cleveland Clinic researchers have discovered that testosterone may suppress glioblastoma growth in men. An analysis of over 1,300 patients revealed that supplemental testosterone is associated with a 38% lower risk of death, potentially paving the way for new treatments.
HealthScience & TechnologyPolitics and GovernmentMedical ScienceFederal GovernmentEducation Medical ResearchCancerMen's HealthGlioblastomaTestosteroneCleveland ClinicNational Institutes of Health